Posted on 8月 31, 20228/31/22
Single-Cell Multiomics: Opportunities, Challenges, and the Evolving Business Model
Posted on 8月 5, 20228/5/22
Three Keys to Value for Unlocking the Promise of Cell Therapies
Posted on 6月 21, 20226/21/22
Challenges of Scaling Up Cell Therapy to New Geographies
Posted on 5月 6, 20225/6/22
Case Study: Defining the Rare Disease Patient Journey to Support Commercialization of Therapy
Posted on 3月 23, 20223/23/22
How Do We Pay for a Cure? How to Put a Price on Life-changing Treatments
Posted on 3月 22, 20223/22/22
Podcast: Achieving Cell and Gene Therapy Commercial Excellence
Posted on 3月 11, 20223/11/22
Gene Therapy in Today’s Digital World
Posted on 2月 24, 20222/24/22
THINK BEYOND THE THERAPY: Demystifying the Complexities of Cell and Gene Therapy Commercialization
Posted on 1月 11, 20221/11/22
A YEAR OF ACTION: Why Data-Backed, Integrated Commercialization Strategies Are Must-haves in 2022
Posted on 12月 2, 202112/2/21